CTOs on the Move

Milestone Pharmaceuticals

www.milestonepharma.com

 
Milestone was founded in 2005 with the underlying concept to base its drug development programs on clinically validated mechanisms of action in order to mitigate as much drug development risk as possible. The company has raised a total of $34 million in venture capital financing since 2006. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. The drug hunters proposed NCE projects based on clinically proven science to form the basis of Milestone’s drug development programs. Milestone has a seasoned management team with experience in ...
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.milestonepharma.com
  • 1111 Dr Frederik Philips Blvd Suite 420
    Saint Laurent, QC CAN H4M 2X6
  • Phone: 514.336.0444

Executives

Name Title Contact Details
Debbie Everidge
Vice President Information Technology Profile

Funding

Milestone Pharmaceuticals raised $17M on 06/15/2015
Milestone Pharmaceuticals raised $55M on 08/01/2017
Milestone Pharmaceuticals raised $80M on 10/25/2018

Similar Companies

Venture Technology Group

Venture Technology Group is a Farmington Hills, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fastrack Pharmaceuticals

Fastrack Pharmaceuticals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Center for Autism and Related Disorders

The Center for Autism and Related Disorders, Inc.

Delcath

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company`s proprietary percutaneous hepatic perfusion (PHP) system is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In the United States, the PHP system is being developed under the tradename HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system), or HEPZATO, and is considered a combination drug and device product regulated by the United States Food and Drug Administration (FDA).